BRICS Microwave Ablation Market (2022-2033)

The Surge in Cancer Cases

The BRICS microwave ablation market is being shaped by a rapid rise in cancer incidence across member countries, driven by demographic changes, urbanization, and shifts in lifestyle patterns. The majority of the aging population is at higher risk of cancer, resulting in substantial increases in diagnoses of common solid tumors. Healthcare systems are thus encountering greater demand for effective treatment options that can address a widening spectrum of oncological needs, particularly where conventional surgery may carry elevated risk or resource strain.

Healthcare providers are responding to this surge by expanding capacity for interventional oncology services. In many major medical centers, there is a clear trend toward adopting minimally invasive therapies that can help manage growing caseloads without overextending surgical infrastructure. Microwave ablation has emerged as a compelling choice in this context, offering a less invasive alternative for treating tumors in organs such as the liver and lungs while supporting shorter recovery times compared with traditional open surgery.

At the same time, governments and healthcare institutions are increasingly prioritizing investment in cancer care infrastructure, including diagnostic imaging and interventional technologies. This focus not only enhances early detection and treatment planning but also expands clinical pathways where technologies like microwave ablation can be utilized. As the overall cancer burden continues to rise, demand for microwave ablation systems and procedural capability is expected to grow in parallel with broader efforts to strengthen oncology care systems across the region.

Increased Demand for Precision Cancer Medicine

Precision cancer medicines are treatment strategies tailored to the biological and clinical characteristics of individual patients. Clinicians are increasingly moving away from one‑size‑fits‑all approaches, instead favoring therapies that can be adapted to tumor type, patient health status, and expected treatment response. Microwave ablation fits well within this paradigm, providing targeted treatment that can be customized to the size and location of tumors while minimizing impact on surrounding healthy tissue.

Multidisciplinary care models are gaining traction in BRICS healthcare settings, with teams of oncologists, interventional specialists, and diagnostic radiologists working collaboratively to design tailored treatment plans. This integrated approach encourages the incorporation of technologies that support precise intervention, particularly for patients who may benefit from localized tumor destruction without extensive surgical intervention. Microwave ablation’s compatibility with real‑time imaging and its ability to deliver controlled thermal energy align with clinicians’ goals for precision and adaptability.

Patient expectations are also contributing to the rising demand for personalized cancer therapies. As awareness of minimally invasive and targeted treatment options grows, many patients and referring physicians are seeking alternatives that offer effective tumor control with fewer complications and faster recovery. Microwave ablation’s profile as a patient‑centric therapy, which can be adjusted to individual clinical conditions, resonates with this demand. As a result, the market for microwave ablation in the BRICS region is anticipated to expand, supported by both clinical preference for precision medicine and patient‑driven interest in tailored cancer care.

The "BRICS Microwave Ablation Market Size and Forecast (2022-2033)" report provides a detailed analysis of the market covering below areas:

• BRICS Microwave Ablation market size and forecast at regional, and country levels for all market segments covered under the scope
• BRICS Microwave Ablation market trends, as well as drivers, restraints, and opportunities
• BRICS Microwave Ablation market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the BRICS Microwave Ablation market
• Detailed company profiles, including SWOT analysis

The geographical scope of the BRICS microwave ablation market report is divided into Russia, Brazil, South Africa, India, China, Egypt, Indonesia, Saudi Arabia, and the UAE. China held the largest share in 2025.

China is the dominant country for microwave ablation within the BRICS region, driven by a combination of advanced healthcare infrastructure, government support for modern medical technologies, and growing clinical expertise. Major urban hospitals in cities such as Beijing, Shanghai, and Guangzhou serve as centers of excellence for interventional radiology and oncology, integrating microwave ablation into treatment pathways for liver, lung, and other solid tumors. These institutions act as hubs for training and knowledge-sharing, enabling clinicians across the country to adopt and refine ablation techniques effectively. Chinese healthcare providers are increasingly incorporating microwave ablation into clinical practice due to its minimally invasive nature, precision, and ability to reduce hospital stays. Collaborative efforts between hospitals and medical device manufacturers have further facilitated professional education and hands-on training programs, strengthening the skill set of interventional radiologists. While access to these procedures is concentrated in urban areas, ongoing initiatives aim to expand expertise and availability across secondary cities and regional hospitals. China’s emphasis on modern oncology care and precision medicine positions it as a market leader in the BRICS region, setting the standard for microwave ablation adoption and influencing clinical practices in neighboring member countries.

• The report includes qualitative and quantitative data in the BRICS Microwave Ablation market across product type, application, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the BRICS Microwave Ablation market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the BRICS Microwave Ablation market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the BRICS Microwave Ablation market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 10 cover the BRICS Microwave Ablation market segments by product type, application, end user, and geography across Russia, Brazil, South Africa, India, China, Egypt, Indonesia, Saudi Arabia, and the UAE. They cover the market revenue, forecast, and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the BRICS Microwave Ablation market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The BRICS Microwave Ablation market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the BRICS Microwave Ablation market are:

• In January 2025, Baird Medical Investment Holdings Ltd. sponsored and showcased its advanced microwave ablation (MWA) technology at the 4th Sichuan Medical Association Thyroid Disease Conference in China. This initiative reinforced clinical engagement and academic collaboration to promote its MWA offerings in the region.
• In January 2024, Hygea Medical Technology Co., Ltd. announced that its EXCEED microwave ablation system and EXACT series microwave ablation probe received clearance from the U.S. Food and Drug Administration (FDA) after prior approval by China’s National Medical Products Administration (NMPA). This milestone represents a major step in the company’s international expansion of China‑developed tumor ablation products.